INSPIRIS China PMCF Study
NCT: NCT05404880 · ACTIVE_NOT_RECRUITING
NCT IDNCT05404880
StatusACTIVE_NOT_RECRUITING
Start Date2022-07-13
Completion2029-12
Brief Summary
The objective of this post-market trial is to evaluate long term safety and performance of the Edwards Lifesciences INSPIRIS RESILIA aortic valve in Chinese patients in a real-world clinical setting.
Frequently Asked Questions
What is INSPIRIS China PMCF Study?
INSPIRIS China PMCF Study is a clinical trial registered under NCT05404880. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05404880?
The current status of NCT05404880 (INSPIRIS China PMCF Study) is: ACTIVE_NOT_RECRUITING.
When did INSPIRIS China PMCF Study start?
INSPIRIS China PMCF Study started on 2022-07-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.